189 related articles for article (PubMed ID: 35030014)
1. Human ABL1 deficiency syndrome (HADS) is a recognizable syndrome distinct from ABL1-related congenital heart defects and skeletal malformations syndrome.
AlAbdi L; Neuhann T; Prott EC; Schön U; Abdulwahab F; Faqeih E; Alkuraya FS
Hum Genet; 2024 Jun; 143(6):739-745. PubMed ID: 38743093
[TBL] [Abstract][Full Text] [Related]
2. [Cancer in people with an intellectual disability in Germany: prevalence, genetics, and care situation].
Sappok T; Kowalski C; Zenker M; Weißinger F; Berger AW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Mar; 67(3):362-369. PubMed ID: 38334785
[TBL] [Abstract][Full Text] [Related]
3. Pterostilbene in the treatment of inflammatory and oncological diseases.
Liu P; Tang W; Xiang K; Li G
Front Pharmacol; 2023; 14():1323377. PubMed ID: 38259272
[TBL] [Abstract][Full Text] [Related]
4. The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization.
Liu Y; Zhang M; Jang H; Nussinov R
Chem Sci; 2024 Jan; 15(3):1003-1017. PubMed ID: 38239681
[TBL] [Abstract][Full Text] [Related]
5. The landscape of SETBP1 gene expression and transcription factor activity across human tissues.
Whitlock JH; Wilk EJ; Howton TC; Clark AD; Lasseigne BN
PLoS One; 2024; 19(1):e0296328. PubMed ID: 38165902
[TBL] [Abstract][Full Text] [Related]
6. SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities.
Liu Y; Zhang W; Jang H; Nussinov R
Cell Mol Life Sci; 2023 Dec; 81(1):5. PubMed ID: 38085330
[TBL] [Abstract][Full Text] [Related]
7. The Imageable Genome.
Jané P; Xu X; Taelman V; Jané E; Gariani K; Dumont RA; Garama Y; Kim F; Del Val Gomez M; Walter MA
Nat Commun; 2023 Nov; 14(1):7329. PubMed ID: 37957176
[TBL] [Abstract][Full Text] [Related]
8. Cancer and Autism: How PTEN Mutations Degrade Function at the Membrane and Isoform Expression in the Human Brain.
Jang H; Chen J; Iakoucheva LM; Nussinov R
J Mol Biol; 2023 Dec; 435(24):168354. PubMed ID: 37935253
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome.
Yavuz BR; Arici MK; Demirel HC; Tsai CJ; Jang H; Nussinov R; Tuncbag N
NPJ Genom Med; 2023 Nov; 8(1):37. PubMed ID: 37925498
[TBL] [Abstract][Full Text] [Related]
10. The landscape of
Whitlock JH; Wilk EJ; Howton TC; Clark AD; Lasseigne BN
bioRxiv; 2023 Oct; ():. PubMed ID: 37873221
[TBL] [Abstract][Full Text] [Related]
11. Cell phenotypes can be predicted from propensities of protein conformations.
Nussinov R; Liu Y; Zhang W; Jang H
Curr Opin Struct Biol; 2023 Dec; 83():102722. PubMed ID: 37871498
[TBL] [Abstract][Full Text] [Related]
12. Cellular and Molecular Mechanisms in Neurodevelopmental Disorders and Brain Tumors.
Costa M; Vannini E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298419
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK.
Nussinov R; Yavuz BR; Arici MK; Demirel HC; Zhang M; Liu Y; Tsai CJ; Jang H; Tuncbag N
Biophys Rev; 2023 Apr; 15(2):163-181. PubMed ID: 37124926
[TBL] [Abstract][Full Text] [Related]
14. Strategy toward Kinase-Selective Drug Discovery.
Zhang M; Liu Y; Jang H; Nussinov R
J Chem Theory Comput; 2023 Mar; 19(5):1615-1628. PubMed ID: 36815703
[TBL] [Abstract][Full Text] [Related]
15. Localized heterochrony integrates overgrowth potential of oncogenic clones.
Blum N; Harris MP
Dis Model Mech; 2023 Feb; 16(2):. PubMed ID: 36621776
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental disorders, immunity, and cancer are connected.
Nussinov R; Tsai CJ; Jang H
iScience; 2022 Jun; 25(6):104492. PubMed ID: 35712080
[TBL] [Abstract][Full Text] [Related]
17. Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs.
Nussinov R; Zhang M; Maloney R; Liu Y; Tsai CJ; Jang H
J Mol Biol; 2022 Sep; 434(17):167569. PubMed ID: 35378118
[TBL] [Abstract][Full Text] [Related]
18. Allostery, and how to define and measure signal transduction.
Nussinov R; Tsai CJ; Jang H
Biophys Chem; 2022 Apr; 283():106766. PubMed ID: 35121384
[TBL] [Abstract][Full Text] [Related]
19. How can same-gene mutations promote both cancer and developmental disorders?
Nussinov R; Tsai CJ; Jang H
Sci Adv; 2022 Jan; 8(2):eabm2059. PubMed ID: 35030014
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
